CXCL10

CXCL10 Full Name

chemokine (C-X-C motif) ligand 10

CXCL10 Introduction

CXCL10 is a pro-inflammatory chemokine that plays a central role in immune cell recruitment and immune system signaling, particularly during infection and tissue injury. It is strongly induced by interferons and is widely recognized as a key mediator of the CXCL10–CXCR3 axis, which orchestrates the migration of CXCR3-positive immune cells such as T lymphocytes, NK cells, monocytes, macrophages, and dendritic cells. For researchers and clinicians, one of the major challenges is that CXCL10 is not merely a marker of inflammation but an active driver of immune amplification loops, meaning that its overexpression can rapidly escalate localized immune responses into systemic inflammatory damage. This dual role makes CXCL10 both a protective antiviral factor and a potential contributor to immune-mediated pathology, especially in conditions where immune regulation is disrupted.

In viral infections, CXCL10 is consistently upregulated in response to RNA and DNA viruses, including coronaviruses, influenza viruses, and herpesviruses. Once induced, it binds to CXCR3 and triggers downstream signaling cascades that enhance immune cell trafficking to infected tissues, forming a critical line of host defense against viral spread. However, this same mechanism is also linked to tissue injury when the response becomes excessive or prolonged, a common pain point observed in severe respiratory infections and chronic viral persistence. Beyond infectious disease, CXCL10 is increasingly implicated in kidney disorders, where it is produced by intrinsic renal cells such as tubular epithelial cells, podocytes, and mesangial cells under inflammatory stress. Elevated CXCL10 levels have been associated with acute kidney injury, lupus nephritis, glomerulosclerosis, and transplant rejection, highlighting its value as both a biomarker and a mechanistic driver of renal inflammation and impaired vascular repair.

Recent research further reveals that CXCL10 signaling is tightly regulated by receptor complexity and biased intracellular pathways, which adds another layer of difficulty for therapeutic targeting. For instance, CXCR3 phosphorylation "barcode" patterns determine how signals downstream of CXCL10 are interpreted, influencing whether immune responses are pro-inflammatory or more regulated in nature. In parallel, CXCL10 can interact with atypical scavenger receptors such as ACKR2, which modulate its extracellular availability through ligand internalization and clearance, effectively reshaping chemokine gradients in tissues. These findings underscore why targeting CXCL10 in disease is not straightforward: its activity is controlled by a dynamic network of receptors, signaling biases, and regulatory scavengers. As a result, CXCL10 remains a high-value but complex therapeutic target in immunology, infectious disease, and inflammatory organ damage, where precise modulation rather than complete inhibition may be required to achieve clinical benefit without compromising host defense.

Alternate Names for CXCL10

CXCL10; chemokine (C-X-C motif) ligand 10; C7; IFI10; INP10; IP-10; crg-2; mob-1; SCYB10; gIP-10; C-X-C motif chemokine 10; gamma IP10; gamma-IP10; small-inducible cytokine B10; interferon-inducible cytokine IP-10; 10 kDa interferon gamma-induced protein; protein 10 from interferon (gamma)-induced cell line; small inducible cytokine subfamily B (Cys-X-Cys); member 10; NI-0801; HuAIP12

• 1.Elemam NM, et al.; CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections. Viruses. 2022, 14(11):2445.
  2.Gao J, et al.; Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases. Mediators Inflamm. 2020, 2020:6194864.